Immunogen reported $2M in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Amgen AMGN:US $ 31877M 71M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 328M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Emergent Biosolutions EBS:US $ 0.1M 0M
Exelixis EXEL:US $ 0.32M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0.1M
Immunogen IMGN:US $ 2M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.6M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NVS:US $ 913M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M